Dual GIP/GLP-1 agonist — next-generation weight loss
Select an option
Includes physician review, medication, syringes & supplies, and free same-day shipping.
Packaging will display the branding of the licensed pharmacy dispensing your medication along with your prescription information, not the Nuvara branding shown in site images.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, making it one of the most effective weight loss medications available. Clinical trials showed an average weight reduction of up to 22.5%.
Dual-action: targets both GIP and GLP-1 receptors
Once-weekly injection
Typical physician-guided dosing — from your first week as a new patient through long-term maintenance.
How it's taken
Subcutaneous injection
Frequency
Once weekly, same day each week
2.5 mg weekly
Starter dose — no meaningful weight loss expected yet, this is tolerance building.
5 mg → 10 mg weekly
Step up every 4 weeks as tolerated; many patients respond well at 7.5 mg.
10–15 mg weekly
Hold at your effective dose; your provider may step you back down for maintenance.
Your physician sets your final dose after reviewing your intake — the ranges below are typical starting points, not a prescription. Never increase your dose faster than your care plan states; side effects are almost always a titration issue. Message your care team before changing, pausing, or stacking anything.
Complete a brief online health assessment
Provider review within 24 hours
Compounded medication shipped to your door
Ongoing dose titration and monthly check-ins
Complete your intake in under 5 minutes. A licensed physician reviews it within 24 hours.
Packaging will display the branding of the licensed pharmacy dispensing your medication along with your prescription information, not the Nuvara branding shown in site images.
